Jyothy Labs share news, announcements and annual reports
NSE: JYOTHYLABBSE: 532926Household ProductsSmall Cap
Jyothy Labs Limited · Formerly Jyothy Laboratories · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2007
Last close ₹171.91down ₹3.15 (1.80%)BSE ₹172.05
Share price at the NSE close on 30 Oct 2026. Previous close ₹175.06.
30 Oct: open ₹174.45, high ₹175.10, low ₹171.00
52-week range of traded prices to 30 Oct 2026
₹171.00Low, 30 Oct 2026₹322.75High, 30 Oct 2025
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and buyback. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6,313 Cr603rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 22.23
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.97
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.04%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 19.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 20.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,85,76453.8% delivered
Jyothy Labs share news and announcements
834 announcements, routine notices left out, newest first. Page 13 of 17.
Dec 2016
Nov 2016
28 Nov · Court Convened Meeting Updates
17 Nov · Analysts
11 Nov · Redemption
8 Nov · Analysts
Oct 2016
30 Oct · Meeting
30 Oct · Meeting
26 Oct · Legal
Exchange has sought clarification from Jyothy Laboratories Limited with respect to announcement dated 25-Oct-2016, regarding "Jyothy Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on October 25, 2016.".On basis of above the Company is required to clarify following:1. Whether proposed to be listed? If yes, name of the stock exchange(s);2. Tenure of the instrument - date of allotment and date of maturity;3. Coupon/interest offered, schedule of payment of coupon/interest and principal;4. Charge/security, if any, created over the assets;5. Special right/interest/privileges attached to the instrument and changes thereof;6. Delay in payment of interest / principal amount for a period of more than three months from the due date or default in payment of interest / principal;7. Details of any letter or comments regarding payment/non-payment of interest, principal on due dates, or any other matter concerning the security and /or the assets along with its comments thereon, if any;8. Details of redemption of preference shares indicating the manner of redemption (whether out of profits or out of fresh issue) and debentures.The response of the Company is awaited.25 Oct · Board meeting
25 Oct · Results
Sep 2016
16 Sep · Analysts
Aug 2016
26 Aug · Analysts
12 Aug · Legal
Exchange has sought clarification from Jyothy Laboratories Limited with respect to an announcement submitted to the Exchange dated August 11, 2016, that the Board of Directors of the Company at its meeting held on August 11, 2016 have Accepted resignation of Mr. Bipin R. Shah as the Independent Director of the Company with immediate effect.On basis of above Company are required to clarify following -1. Reason for resignationThe response of the Company is awaited.8 Aug · Analysts
Jul 2016
Jun 2016
28 Jun · Analysts
15 Jun · Analysts
May 2016
23 May · Board meeting
13 May · Analysts
12 May · Board meeting
Inter-alia, to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2016 and to consider and recommend final dividend, if any, on the Equity Shares of the Company for the financial year 2015-16.
Apr 2016
Mar 2016
4 Mar · Corporate action
Feb 2016
15 Feb · Updates
Jan 2016